HFCAS OpenIR

浏览/检索结果: 共4条,第1-4条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Effective pH-Activated Theranostic Platform for Synchronous Magnetic Resonance Imaging Diagnosis and Chemotherapy 期刊论文
ACS APPLIED MATERIALS & INTERFACES, 2018, 卷号: 10, 期号: 37, 页码: 31114-31123
作者:  Wang, Dan;  Lin, Haiyan;  Zhang, Guilong;  Si, Yuanchun;  Yang, Hongyi;  Bai, Guo;  Yang, Chi;  Zhong, Kai;  Cai, Dongqing;  Wu, Zhengyan;  Wang, Renfei;  Zou, Duohong
收藏  |  浏览/下载:63/0  |  提交时间:2019/12/20
pH-activated  synchronous  MRI  theranostic platform  tumor chemotherapy  
Nanostructures for pH-sensitive Drug Delivery and Magnetic Resonance Contrast Enhancement Systems 期刊论文
CURRENT MEDICINAL CHEMISTRY, 2018, 卷号: 25, 期号: 25, 页码: 3036-3057
作者:  Sun, Xiao;  Zhang, Guilong;  Wu, Zhengyan
浏览  |  Adobe PDF(4176Kb)  |  收藏  |  浏览/下载:93/47  |  提交时间:2019/12/25
pH-responsive  magnetic resonance contrast agents  drug delivery systems  contrast enhancement  controlled release  cancer diagnosis and chemotherapy  
Evaluation of menopausal status among breast cancer patients with chemotherapy-induced amenorrhea 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2018, 卷号: 30
-
收藏  |  浏览/下载:37/0  |  提交时间:2020/10/26
ADJUVANT CHEMOTHERAPY  AROMATASE INHIBITORS  POSTMENOPAUSAL WOMEN  OVARIAN-FUNCTION  TAMOXIFEN  METAANALYSIS  PREDICTORS  RECOVERY  IMPACT  RISK  Breast neoplasms  drug therapy  amenorrhea  menopause  logistic models  
Clinical significance of miRNA - 106a in non-small cell lung cancer patients who received cisplatin combined with gemcitabine chemotherapy 期刊论文
Cancer Biology & Medicine, 2018, 卷号: 15
作者:  Tian Ye;  Sun Changyu;  Zhang Limeng;  Pan Yuan
收藏  |  浏览/下载:80/0  |  提交时间:2020/12/28
MiRNA-106a  NSCLC  cisplatin  gemcitabine  chemotherapy resistant  Neoplasms. Tumors. Oncology. Including cancer and carcinogens  RC254-282